<DOC>
	<DOCNO>NCT01213121</DOCNO>
	<brief_summary>- To examine difference neurophysiologic parameter unmedicated patient bipolar depression healthy control - To examine within-subject change neurophysiologic parameter patient bipolar depression treat quetiapine</brief_summary>
	<brief_title>Neurophysiologic Changes Patients With Bipolar Depression</brief_title>
	<detailed_description>- Alterations neurophysiologic regulation suggest patient major depressive disorder bipolar disorder - Depressive phase bipolar disorder show multi-faceted characteristic different unipolar depression - Quetiapine atypical antipsychotic license treatment bipolar depression - The aim study investigate pattern neurophysiologic dysregulation bipolar depression change induce quetiapine treatment</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<criteria>DSMIV bipolar disorder I II Depressive phase Drugnaive drugfree Serious medical neurological condition DSMIV substancerelated disorder ( within 12 month prior participation ) Mentally retard</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>bipolar depression</keyword>
	<keyword>heart rate variability</keyword>
	<keyword>cardio-respiratory coupling</keyword>
	<keyword>electroencephalography</keyword>
</DOC>